H. Wagner

Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.

J. Halazun, H. Wagner, J. Gaeta, 1974, Cancer.

Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia

J. Halazun, H. Wagner, J. Gaeta, 1974 .

Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission

B. Pollock, G. Rivera, D. Pinkel, 2000, Cancer.

Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.

L. Frankel, J. Shuster, M. Borowitz, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma.

R. Livingston, W. Sause, A. Turrisi, 2000, Cancer.

Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.

M. Borowitz, D. Head, N. Winick, 1989, Blood.

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group.

H. Deicher, M. Petit, R. Bartl, 1995, European journal of cancer.